Download PDF
Methods Inf Med 1994; 33(05): 514-521
DOI: 10.1055/s-0038-1635049
Original Article
Schattauer GmbH

A Compartmental Model for Simulation of IGF-I Kinetics and Metabolism

M. A. Boroujerdi
1   Department of Medicine, UMDS, St. Thomas’ Campus, London, UK
,
P. H. Sonksen
1   Department of Medicine, UMDS, St. Thomas’ Campus, London, UK
,
R. H. Jones
1   Department of Medicine, UMDS, St. Thomas’ Campus, London, UK
› Author Affiliations
Further Information

Publication History

Publication Date:
12 February 2018 (online)

    Permissions and Reprints

Abstract:

A compartmental model for the simulation of in-vivo insulin-like growth factor one (IGF-I) kinetics and metabolism is presented. The model is based on the concept that IGF binding proteins (IGFBPs) act as a reservoir for IGF-I in plasma, thereby restricting its access to the extravascular space. The model is divided into two subsystems; a binding model for IGF-I and IGFBP, and an IGF-I clearance model, which includes the binding of IGF-I to IGF-I receptors. The non-linear differential equations describing the model are based on the law of mass action. Given the steady state condition, the linearized form of the model, describing tracer kinetics of IGF-I and IGFBPs is developed. It is demonstrated that using the available data, it is possible to assign values to the model parameters, thereby allowing simulation of the model to obtain information not accessible by direct observation.

Keywords:

Compartmental Model - Simulation - Modelling - Pharmacokinetics
 

  • REFERENCES

  • 1 Rechler MM, Brown AL. Insulin-like growth factors binding proteins: Gene structure and expression. Growth Regulation 1992; 02: 55-68.
    PubMedGoogle Scholar
  • 2 Vicki RS, Hall K. Insulin-growth factors and their binding proteins. Am J Physiol 1990; 70: 591-614.
    PubMedGoogle Scholar
  • 3 Bach LA, Rechler MM. Insulin like growth factors and diabetes. Diabetes/Metabolism Reviews 1992; 08: 229-57.
    CrossrefPubMedGoogle Scholar
  • 4 Jones RH, Sonksen PH, Boroujerdi MA, Carson ER. Number and affinity of insulin receptors in intact human subjects. Diabetologia 1984; 27: 207-11.
    PubMedGoogle Scholar
  • 5 Hovorka R, Powrie JK, Smith GD, Sonksen PH, Carson ER, Jones RH. Five compartment model of insulin kinetics and its use to investigate action of chloroquine in NIDDM. Am J Physiol 1993; 265: E162-75.
    PubMedGoogle Scholar
  • 6 Zapf J, Hauri C, Waldvogel M, Froesch ER. Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats. J Clin Invest 1986; 77: 1768-75.
    CrossrefPubMedGoogle Scholar
  • 7 Segel LA. Modeling Dynamic Phenomena in Molecular and Cellular Biology. London: Cambridge Press; 1987
    Google Scholar
  • 8 Press WH, Flannery BP, Teukolsky SA, Vet-terling WT. Numerical Recipes in Pascal. Cambridge: Cambridge University Press; 1991
    Google Scholar
  • 9 Young SCI, Miles MV, Clemmons DR. Determination of the pharmacokinetic profile of insulin-like growth factor binding proteins-1 and -2 in rats. Endocrinology 1992; 131: 1867-73.
    CrossrefPubMedGoogle Scholar
  • 10 Conover CA, Butler PC, Wang MW, Rizza RA. Lack of growth hormone effect on insulin associated suppression of insulinlike growth factor binding protein 1 in humans. Diabetes 1990; 39: 1251-6.
    CrossrefPubMedGoogle Scholar
  • 11 Godfrey KR. Compartmental Models and their Application. London: Academic Press; 1983
    Google Scholar
  • 12 Ganong WF. Review of Medical Physiology. Norwalk: Appleton and Lange; 1989
    Google Scholar
  • 13 Anderson DH. Compartmental Modelling and Tracer Kinetics. Berlin: Springer; 1983
    Google Scholar
  • 14 Laron Z, Klinger B, Silbergeld A, Lewin R, Erster B, Gil-Ad I. Intravenous administration of recombinant IGF-I lowers serum GHRH and TSH. Acta Endocrinologica (Copenh) 1990; 123: 378-82.
    PubMedGoogle Scholar
  • 15 Hodgkinson SC, Davis SR, Burleigh BD, Henderson HV, Gluckman PD. Metabolic clearance rate of insulin-like growth factor-I in fed and starved sheep. J Endocrinol 1987; 115: 233-40.
    CrossrefPubMedGoogle Scholar
  • 16 Carson ER, Cobelli C, Finkelstein L. The Mathematical Modelling of Metabolic and Endocrine Systems. New York: John Wiley; 1983
    Google Scholar
  • 17 DiStefano JJ. Optimized blood sampling protocols and sequential design of kinetics experiments. Am J Physiol 1981; 240: R259-65.
    PubMedGoogle Scholar
  • 18 Guler HP, Zapf J, Schmid C, Froesch ER. Insulin-like growth factors I and II in healthy man. Acta Endocrinologica (Copenh) 1989; 121: 753-8.
    PubMedGoogle Scholar
  • 19 Baxter RC, Martin JL. Radioimmunoassay of growth hormone-dependent insulin like growth factor binding protein in human plasma. J Clin Invest 1986; 78: 1504-12.
    CrossrefPubMedGoogle Scholar
  • 20 Davenport ML, Clemmons DR, Miles MV, Camacho-Hubner C, D’Ercole AJ, Underwood LE. Regulation of serum insulin-like growth factor I (IGF-I) and IGF binding protein during rat pregnancy. Endocrinology 1990; 127: 1278-86.
    CrossrefPubMedGoogle Scholar
  • 21 Lowe WL, Adamo M, Werner H, Roberts CT, LeRoith D. Regulation by fasting of rat insulin-like growth factor I and its receptor. J Clin Invest 1989; 84: 619-26.
    CrossrefPubMedGoogle Scholar
  • 22 Kolaczynski JW, Caro JF. Insulin-like growth factor I therapy for diabetes meilitus. Diabetes Care 1994; 17: 92-6.
    CrossrefPubMedGoogle Scholar